Rearrangement of spiro-benzimidazolines: preparation of N-alkenyl- and N-alkyl-benzimidazol-2-ones

Tetrahedron

Volumn 63, Issue 46, 2007, Pages 11489-11502

  Kuethe, Jeffrey T ^a   Varon, Jack ^a   Childers, Karla G ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZIMIDAZOL 2 ONE DERIVATIVE; BENZIMIDAZOLE DERIVATIVE; BORANE DERIVATIVE; DROPERIDOL; OPIATE ANTAGONIST; PHENYLENEDIAMINE; PHOSGENE; POTASSIUM CARBONATE; SPIRO COMPOUND; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; CYCLIZATION; DRUG STRUCTURE; DRUG SYNTHESIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLYMERIZATION; PRIORITY JOURNAL; REACTION ANALYSIS; REPRODUCIBILITY;

EID: 34848880466     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2007.06.106     Document Type: Article

References (85)

1. Preston R.M. In: Preston P.M. (Ed). Chemistry of Heterocyclic Compounds Vol. 40 (1980), Wiley Interscience, New York, NY 531-542 Part 2, Chapter 10
2. Rémond G., Portevin B., Bonnet J., Cnaet E., Regoli D., and De Nanteuil G. Eur. J. Med. Chem. 32 (1997) 843-868
3. Zuev D., Michne J.A., Huang H., Beno B.R., Wu D., Gao Q., Torrente J.R., Xu C., Conway C.M., Macor J.E., and Dobowchik G.M. Org. Lett. 7 (2005) 2465-2468
4. Li Q., Li T., Woods K.W., Gu W.-Z., Cohen J., Stoll V.S., Galicia T., Hutchins C., Frost D., Rosenberg S.H., and Sham H.L. Bioorg. Med. Chem. Lett. 15 (2005) 2918-2922
5. Dombroski M.A., Letavic M.A., McClure K.F., Barberia J.T., Carty T.J., Cortina S.R., Csiki C., Dipesa A.J., Elliott N.C., Gabel C.A., Jordan C.K., Labasi J.M., Martin W.H., Pesse K.M., Stock I.A., Svensson L., Sweeney F.J., and Yu C.H. Bioorg. Med. Chem. Lett. 14 (2004) 919-923
6. McClure K.F., Abramov Y.A., Laird E.R., Barberia J.T., Cai W., Carty T.J., Cortina S.R., Danley D.E., Dipesa A.J., Donahue K.M., Dombroski M.A., Elliot N.C., Gabel C.A., Han S., Hynes T.R., LeMotte P.K., Mansour M.N., Marr E.S., Letavic M.A., Pandit J., Ripin D.B., Sweeney F.J., Tan D., and Tao Y. J. Med. Chem. 48 (2005) 5728-5737
7. Gustin D.J., Sehon C.A., Wei J., Cai H., Meduna S.P., Khatuya H., Sun S., Gu Y., Jiang W., Thurmond R.L., Karlsson L., and Edwards J.P. Bioorg. Med. Chem. Lett. 15 (2005) 1687-1691
8. Tapia I., Alonso-Cires L., Lópes-Tudanca P.L., Mosquera R., Labeaga L., Innerárity A., and Orjales A. J. Med. Chem. 42 (1999) 2870-2880
9. Zhang P., Terefenko E.A., Wrobel J., Zhang Z., Zhu Y., Cohen J., Marschke K.B., and Mais D. Bioorg. Med. Chem. Lett. 11 (2001) 2747-2750
10. Terefenko E.A., Kern J., Fensome A., Wrobel J., Zhu Y., Cohen J., Winneker R., Zhang Z., and Zhang P. Bioorg. Med. Chem. Lett. 15 (2005) 3600-3603
11. Yu K.-L., Zhang Y., Civiello R.L., Trehan A.K., Pearce B.C., Yin Z., Combrink K.D., Gulgeze H.B., Wang X.A., Kadow K.F., Cianci C.W., Krystal M., and Meanwell N.A. Bioorg. Med. Chem. Lett. 14 (2004) 1133-1137
12. Yu K.-L., Wang X.A., Civiello R.L., Trehan A.K., Pearce B.C., Yin Z., Combrink K.D., Gulgeze H.B., Zhang Y., Kadow K.F., Cianci C.W., Clarke J., Genovesi E.V., Medina I., Lamb L., Wyde P.R., Krystal M., and Meanwell N.A. Bioorg. Med. Chem. 16 (2006) 1115-1122
13. Guillaume M. Org. Process Res. Dev. 10 (2006) 1227-1230 and referenced cited therein
14. Howard H.R., Sarges R., Siegel T.W., and Beyer T.A. Eur. J. Med. Chem. 27 (1992) 779-789
15. Turconi M., Nicola M., Gil Qunitero M., Maiocchi L., Micheletti R., Giraldo E., and Donetti A. J. Med. Chem. 33 (1990) 2101-2108
16. Flynn, D. L.; Moormann, A. D. U.S. Patent 5,300,512, April 5, 1994;
17. Köppe, H.; Mestrup, A.; Reath, E.-O.; Schromm, K.; Hoefke, W.; Muacevic, C. U.S. Patent 4,381,309, April 26, 1983.
18. Henning R., Lattrell R., Gerhards H.J., and Leven M. J. Med. Chem. 30 (1987) 814-819
19. Hara, H.; Maruyama, T.; Saito, M.; Takeuchi, M.; Toshiyasu, M. U.S. Patent 5,162,318, November 10, 1992.
20. McKay M.C., Dworetzky S.I., Meanwell N.A., Olesen S.-P., Reinhart P.H., Levitan I.B., Adelman J.P., and Gribkoff V.K. J. Neurophysiol. 71 (1994) 1873-1882
21. Gribkoff V.K., Champigny F., Barbry P., Dworetzky S.I., Meanwell N.A., and Lazdunski M. J. Biol. Chem. 269 (1994) 10983-10986
22. Olesen S.-P., Munch E., Wätjen F., and Drejer J. NeuroReport 5 (1994) 1001-1004
23. Olesen S.-P., Munch E., Moldt P., and Drejer J. Eur. J. Pharmacol. 251 (1994) 53-98
24. See Ref. 2
25. Baragatti B., Biagi G., Calderone V., Giorgi I., Livi O., Martinotti E., and Scartoni V. Eur. J. Med. Chem. 35 (2000) 949-955
26. For an excellent discussion, see:. Meanwell N.A., Sit S.Y., Gao J., Wong H.S., Gao Q., St. Laurent D.R., and Balasubramanian N. J. Org. Chem. 60 (1995) 1565-1582 and references cited therein
27. This general approach involves nucleophilic displacement of a 2-fluoro(or chloro)-nitrobenzene with an amine or aniline followed by reduction of the nitro group and cyclization to the benzimidazol-2-one ring system. For a few leading references, see Refs. 4,5b,6,7,13. For an approach to benzimidazol-2-thiones employing these general conditions, see:. Sato M., Arimoto M., Ueno K., Kojima H., Yamasaki T., Sakauai T., and Kasahara A. J. Med. Chem. 21 (1978) 1116-1120
28. {A figure is presented}
29. Davoll J., and Laney D.H. J. Chem. Soc. (1960) 314-318
30. Rossi A., Hunger A., Kebrle J., and Hoffmann K. Helv. Chim. Acta 43 (1960) 1298-1313
31. Rossi A., Hunger A., Kebrle J., and Hoffmann K. Helv. Chim. Acta 43 (1960) 1046-1056
32. For additional references, see:
33. De Risi C., Pollini G.P., Trapella C., Peretto I., Ronzoni S., and Giardina G.A.M. Bioorg. Med. Chem. 9 (2001) 1871-1877
34. Barreca M.L., Rao A., De Luca L., Zappalà M., Monforte A.-M., Maga G., Rannecouque C., Balzarini J., De Clercq E., Chimirri A., and Monforte P. J. Med. Chem. 48 (2005) 3433-3437
35. See Ref 8a.
36. For leading references, see:
37. Xu X.-J., and Zong Y.-X. Tetrahedron Lett. 48 (2007) 129-132
38. Wang C.-C., and Li W.-R. J. Comb. Chem. 6 (2004) 899-902
39. Pan P.-C., and Sun C.-M. Tetrahedron Lett. 40 (1999) 6443-6446
40. Huang W., and Scarborough R.M. Tetrahedron Lett. 40 (1999) 2665-2668
41. Raju B., Nguyen N., and Holland G.W. J. Comb. Chem. 4 (2002) 320-328
42. Lee J., Gauthier D., and Rivero R.A. Tetrahedron Lett. 39 (1998) 201-204
43. Yeh C.-M., Tung C.-L., and Sun C.-M. J. Comb. Chem. 2 (2000) 341-348
44. Wei G.P., and Phillips G.B. Tetrahedron Lett. 39 (1998) 179-182
45. Yeh C.-M., and Sun C.-M. Tetrahedron Lett. 40 (1999) 7247-7250
46. Kilburn J.P., Lau J., and Jones R.C.F. Tetrahedron Lett. 41 (2000) 5419-5422
47. Lee B.S., Makajan S., Chapman B., and Janda K.D. J. Org. Chem. 69 (2004) 3319-3329
48. McLaughlin M., Palucki M., and Davies I.W. Org. Lett. 8 (2006) 3311-3314
49. For additional references, see:
50. Israel M., Jones L.C., and Modest E.J. Tetrahedron Lett. 9 (1968) 4811-4814
51. Israel M., and Jones L.C. J. Heterocycl. Chem. 6 (1969) 735-738
52. Israel M., and Jones L.C. J. Heterocycl. Chem. 8 (1971) 797-802
53. Israel M., Tinter S.K., Trites D.H., and Modest E.J. J. Heterocycl. Chem. 7 (1970) 1029-1035
54. Israel M., Jones L.C., and Joullié M.M. J. Heterocycl. Chem. 8 (1971) 1015-1018
55. Meth-Cohn O., and Smith D.I. J. Chem. Soc., Perkin Trans. 1 (1986) 261-268
56. Van den Branden S., Compernolle F., and Hoornaert G.J. Tetrahedron 48 (1992) 9753-9766
57. Baens N.P., Compernolle F., Toppert S.M., and Hoornaert G.J. Tetrahedron 49 (1993) 3193-3202
58. Rodgers J.D., Caldwell G.W., and Gauthier A.D. Tetrahedron Lett. 33 (1992) 3273-3276
59. Taniguchi K., Shigenaga S., Ogahara T., Fujitsu T., and Matsuo M. Chem. Pharm. Bull. 41 (1993) 301-309
60. Janssen, P. A. J. U.S. Patent 3,161,645, December 15, 1964.
61. Hazelton J.C., Iddon B., Redhouse A.D., and Suschitzky H. Tetrahedron 51 (1995) 5597-5608
62. Hazelton J.C., Iddon B., Suschitzky H., and Wolley L.H. Tetrahedron 51 (1995) 10771-10794
63. For leading references, see:
64. Davies K.E., Domany G.E., Farhat M., Herbert J.A.L., Jefferson A.M., Guttierrez Martin M.d.l.A., and Suschitzky H. J. Chem. Soc., Perkin Trans. 1 (1984) 2465-2475
65. Iddon B., Robinson A.G., and Suschitzky H. Synthesis (1988) 871-876
66. Herbert J.A.L., Iddon B., Robinson A.G., and Suschitzky H. J. Chem. Soc., Perkin Trans. 1 (1988) 991-997
67. Hazelton J.C., Iddon B., Suschitzky H., and Woolley L.H. J. Chem. Soc., Perkin Trans. 1 (1992) 685-691
68. Iddon B., Kutschy P., Robinson A.G., Suschitzky H., Kramer W., and Neugebauer F.A. J. Chem. Soc., Perkin Trans. 1 (1992) 3129-3134
69. Schwoch S., Kramer W., Neidlein R., and Suschitzky H. Helv. Chim. Acta 77 (1994) 2175-2190
70. Reddy G.M., Prasunamba P.L., and Reddy P.S.N. Tetrahedron Lett. 37 (1996) 3355-3358
71. For leading references, see:
72. Prakash G.K., Mathew T., Panja C., Vaghoo H., Venkataraman K., and Olah G.A. Org. Lett. 9 (2007) 179-182
73. Trivedi R., De S.K., and Gibbs R.A. J. Mol. Catal. A: Chem. 245 (2006) 8-11
74. Itoh K., Hideaki I., and Chikashita H. Chem. Lett. (1982) 1117-1118
75. Smith J.G., and Ho I. Tetrahedron Lett. 12 (1971) 3541-3544
76. Morales H.R., Bulbarela A., and Contreras R. Heterocycles 24 (1986) 135-139
77. Curini M., Epifano F., Marcotullio M.C., and Rosati O. Tetrahedron Lett. 42 (2001) 3193-3195
78. Wang Z.-X., and Qin H.-L. J. Heterocycl. Chem. 42 (2005) 1001-1005
79. Varala R., Enugala R., Nuvula S., and Adapa S.R. Synlett (2006) 1009-1014 and references cited therein
80. Poulain R., Horvath D., Bonnet B., Eckhoff C., Chapelain B., Bodinier M.-C., and Déprez B. J. Med. Chem. 44 (2001) 3378-3390
81. Sui Z., De Voss J.J., DeCamp D.L., Li J., Craik C.S., and Ortiz de Montellano P.R. Synthesis (1993) 803-808
82. Garner R., Garner G.V., and Suschitzky H. J. Chem. Soc. C (1970) 825-829
83. Eiden F., and Schulte E. Arch. Pharmacol. 309 (1976) 675-678
84. Scalzo M., Massa S., De Martino G., Giuliano R., Artico M., Dolfini E., and Morasca L. Farmaco 39 (1974) 459-472
85. Obase H., Takai H., Teranishi M., and Nobuhiro N. J. Heterocycl. Chem. 20 (1983) 565-573